99 related articles for article (PubMed ID: 17348441)
1. Scintimammography with a hybrid SPECT/CT imaging system.
Schillaci O; Danieli R; Filippi L; Romano P; Cossu E; Manni C; Simonetti G
Anticancer Res; 2007; 27(1B):557-62. PubMed ID: 17348441
[TBL] [Abstract][Full Text] [Related]
2. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Picardi V; Cannas P; Colella AC
Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
[TBL] [Abstract][Full Text] [Related]
5. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
6. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography.
Usmani S; Niaz K; Maseeh-Uz-Zaman ; Niyaz K; Khan HA; Habib S; Kamal S
Nucl Med Commun; 2007 Nov; 28(11):842-6. PubMed ID: 17901766
[TBL] [Abstract][Full Text] [Related]
7. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas.
Spanu A; Schillaci O; Meloni GB; Porcu A; Cottu P; Nuvoli S; Falchi A; Chessa F; Solinas ME; Madeddu G
Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623
[TBL] [Abstract][Full Text] [Related]
10. Scintimammography with a high resolution dedicated breast camera in comparison with SPECT/CT in primary breast cancer detection.
Spanu A; Chessa F; Sanna D; Cottu P; Manca A; Nuvoli S; Madeddu G
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):271-80. PubMed ID: 18596669
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
12. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography?
Mathieu I; Mazy S; Willemart B; Destine M; Mazy G; Lonneux M
J Nucl Med; 2005 Oct; 46(10):1574-81. PubMed ID: 16204705
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
14. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Aziz A; Hashmi R; Ogawa Y; Hayashi K
Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
[TBL] [Abstract][Full Text] [Related]
16. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of planar and SPECT scintimammography with 99mTc-sestamibi in the diagnosis of breast carcinoma.
Danielsson R; Boné B; Agren B; Svensson L; Aspelin P
Acta Radiol; 1999 Mar; 40(2):176-80. PubMed ID: 10080730
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer.
Lumachi F; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Geatti O; Brandes AA; Bui F
Eur J Nucl Med; 2001 Dec; 28(12):1776-80. PubMed ID: 11734915
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
